Tekla Life Financials
| HQL Stock | USD 14.74 0.28 1.86% |
Tekla |
Understanding current and past Tekla Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tekla Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Tekla Life's assets may result in an increase in income on the income statement.
Tekla Life Stock Summary
Tekla Life competes with Tekla World, Tekla Healthcare, Royce Value, John Hancock, and Tekla Healthcare. Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Asset Management classification in the United States and is traded on New York Stock Exchange.Specialization | Financial Services, Financial Services |
| Instrument | USA Stock View All |
| Exchange | New York Stock Exchange |
| ISIN | US87911K1007 |
| CUSIP | 87911K100 404053100 |
| Location | Massachusetts; U.S.A |
| Business Address | 1900 Market Street, |
| Sector | Capital Markets |
| Industry | Financials |
| Benchmark | Dow Jones Industrial |
| Website | www.teklacap.com/hql.html |
| Phone | 215 405 5700 |
| Currency | USD - US Dollar |
Tekla Life Key Financial Ratios
Tekla Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tekla Life's current stock value. Our valuation model uses many indicators to compare Tekla Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tekla Life competition to find correlations between indicators driving Tekla Life's intrinsic value. More Info.Tekla Life Sciences is rated # 2 in return on equity category among its peers. It is rated # 3 in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Tekla Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Tekla Life Sciences Systematic Risk
Tekla Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tekla Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Tekla Life Sciences correlated with the market. If Beta is less than 0 Tekla Life generally moves in the opposite direction as compared to the market. If Tekla Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tekla Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tekla Life is generally in the same direction as the market. If Beta > 1 Tekla Life moves generally in the same direction as, but more than the movement of the benchmark.
Tekla Life November 14, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tekla Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tekla Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tekla Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Tekla Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tekla Life's daily price indicators and compare them against related drivers.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 4.04 | |||
| Value At Risk | (1.51) | |||
| Potential Upside | 1.43 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Life. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Tekla Life Sciences is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Life's value that differs from its market value or its book value, called intrinsic value, which is Tekla Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Life's market value can be influenced by many factors that don't directly affect Tekla Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.